Suprascapular neuropathy

Jina Rachel Park MD (

Dr. Park of New York University Langone Medical Center has no relevant financial relationships to disclose.

Howard W Sander MD (

Dr. Sander of the New York University Grossman School of Medicine received honorariums from Grifols for consulting work.

Randolph W Evans MD, editor. (

Dr. Evans of Baylor College of Medicine received honorariums from Allergan, Amgen, Biohaven, Lilly, Novartis, and Teva for speaking engagements.

Originally released June 1, 2001; last updated October 20, 2020; expires October 20, 2023


Suprascapular neuropathy is an underappreciated cause of shoulder girdle weakness and pain. The clinical and electrophysiologic techniques of diagnosis can be easily learned. Advances in correlation of nerve conduction study results with treatment choices and outcomes provide a motor-based prognostic model for suprascapular neuropathy. Both nonoperative and operative treatments are successful when properly chosen. In this update, new data regarding diagnostic modalities, etiologies, risk factors, and treatments of suprascapular neuropathy are summarized.

Key points


• Suprascapular neuropathy should be considered in patients with shoulder pain, weakness, and supraspinatus and infraspinatus muscle atrophy.


• Suprascapular neuropathy could be common in patients with a history of shoulder trauma, rotator cuff tear, and in overhead sport players.


• The gold standard for the diagnosis of suprascapular neuropathy is electrodiagnostic testing.

Historical note and terminology

Suprascapular neuropathy connotes injury to the suprascapular nerve anywhere in its course, from the origin at the brachial plexus to its termination in the infraspinatus muscle. Suprascapular neuropathy is a more common cause of shoulder pain and weakness than is generally believed (Rengachary et al 1979a; Vastamaki and Goransson 1993). Despite its relatively low prevalence, it must be kept in mind as a potential cause of shoulder pain, particularly in patients where the history, physical examination, and imaging studies do not adequately explain a patient's symptoms or disability (Moen et al 2012).

Shoulder girdle neuropathy was reported as early as 1879 (Joffroy 1879), and in 1909, isolated "neuritis" of the suprascapular nerve was described (Ewald 1909). In 1926, 16 cases of suprascapular neuropathy were published in a review of war injuries, and an additional case was discussed in 1936 (Foster 1926; Thomas 1936).

In Parsonage and Turner's classic publication of Neuralgic Amyotrophy in 1948, 4 cases of isolated suprascapular neuropathy are described (Parsonage and Turner 1948).

In the late 1950s, Kopell and Thompson were the first to define a suprascapular neuropathy syndrome. In a series of publications, they defined pathophysiology, clinical characteristics, and treatment approaches for suprascapular nerve entrapment at the suprascapular notch (Kopell and Thompson 1959; Kopell and Thompson 1963).

Gassel was the first to publish nerve conduction study techniques for the suprascapular nerve, and Kraft further defined these methods (Gassel 1964; Kraft 1972). A report of isolated infraspinatus involvement in suprascapular neuropathy was described in 1982 (Aiello et al 1982). Increasing attention to the importance of the various presentations and treatments of suprascapular neuropathy has continued to the present.

The content you are trying to view is available only to logged in, current MedLink Neurology subscribers.

If you are a subscriber, please log in.

If you are a former subscriber or have registered before, please log in first and then click select a Service Plan or contact Subscriber Services. Site license users, click the Site License Acces link on the Homepage at an authorized computer.

If you have never registered before, click Learn More about MedLink Neurology  or view available Service Plans.

Find out how you can join MedLink Neurology